Evidence map›Paper›PMID 41449370›Full record

SynthesisBMC infectious diseases2025

Viral cultures for assessing airborne infectiousness of SARS-CoV-2: a systematic review and meta-analysis.

Igho J Onakpoya, Annette Plüddemann, Elena C Rosca, Sara Gandini, Susanna Maltoni, Jon Brassey, Tom Jefferson, Carl J Heneghan, David H Evans, John M Conly

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Igho J OnakpoyaDepartment for Continuing Education, University of Oxford, Oxford, UK. igho.onakpoya@conted.ox.ac.uk.
Annette PlüddemannCentre for Evidence Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Elena C RoscaVictor Babes University of Medicine and Pharmacy, Timisoara, Romania.
Sara GandiniDepartment of Experimental Oncology, IEO European Institute of Oncology IRCCS, Milan, 20141, Italy.
Susanna MaltoniClinical Trial Centre Unit, IRCCS Azienda Ospedaliero - Universitaria di Bologna, Bologna, Italy.
Jon BrasseyTrip Database Ltd, Newport, UK.
Tom JeffersonDepartment for Continuing Education, University of Oxford, Oxford, UK.
Carl J HeneghanCentre for Evidence Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
David H EvansDepartment of Medical Microbiology & Immunology, Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, T6G 2E1, Canada.
John M ConlyDepartments of Medicine, Microbiology, Immunology & Infectious Diseases, and Pathology & Laboratory Medicine, Snyder Institute for Chronic Diseases and O'Brien Institute for Public Health, Cumming School of Medicine, University of Calgary and Alberta Health Services, Calgary, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThere is uncertainty about the quantification, viability and infectivity of SARS-CoV-2 in air samples. Our objective was to systematically review the evidence for air sample virus infectiousness with high-level confirmatory studies.

methodsWe conducted literature searches in LitCovid, medRxiv, PubMed, the WHO Covid-19 databases, and Google Scholar. We included studies that assessed viral infectiousness in the air using viral culture or serial qRT-PCR with or without genomic sequencing. Our primary outcome was the proportion of culture-positive air samples of SARS-CoV-2. Secondary outcomes explored the relationship between infectiousness and Cycle threshold (Ct). We used published methods for assessing quality, and R software for meta-analysis.

resultsWe included 26 studies that used viral culture to assess air sample positivity of SARS-CoV-2. The overall reporting quality was moderate. The overall pooled frequency of positive viral cultures was 14% (95% CI 7-17, I

conclusionsThe proportion of positive SARS-CoV-2 viral cultures following positive RNA samples in the air is low, suggesting that while viral RNA may be present, the likelihood of detecting culturable, infectious viruses is substantially lower. Our findings underscore the need for standardized guidelines to assess and report the infectivity and potential for transmissibility of airborne viruses, including the consistent reporting of Ct values and methods to mitigate bias.

Indexed as

Air MicrobiologyCOVID-19SARS-CoV-2Virus CultivationHumansAirborneCOVID-19SARS-CoV-2Systematic reviewTransmissionViral culture

Identifiers

PMID41449370
PMCPMC12888525

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.